<bill session="118" type="s" number="2329" updated="2025-05-27T14:15:48Z">
  <state datetime="2023-07-13">REFERRED</state>
  <status>
    <introduced datetime="2023-07-13"/>
  </status>
  <introduced datetime="2023-07-13"/>
  <titles>
    <title type="display">Emerging Pathogen Preparedness Program Authorization Act</title>
    <title type="short" as="introduced">Emerging Pathogen Preparedness Program Authorization Act</title>
    <title type="official" as="introduced">A bill to establish an emerging pathogen preparedness program within the Food and Drug Administration to improve regulatory oversight of medical countermeasures for future pandemics.</title>
  </titles>
  <sponsor bioguide_id="H000273"/>
  <cosponsors>
    <cosponsor bioguide_id="B001305" joined="2023-07-13"/>
  </cosponsors>
  <actions>
    <action datetime="2023-07-13">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-07-13" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="s" number="2333" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2024-08-20T15:53:29Z" status="Introduced in Senate">Emerging Pathogen Preparedness Program Authorization Act

This bill establishes a program in the Food and Drug Administration's Center for Biologics Evaluation and Research to support the development and approval of biological countermeasures. Authorized activities include the development of quality measures for countermeasures, surveillance programs to monitor countermeasures, and research and development of platform vaccine technology to support emergency use authorization requests.</summary>
</bill>
